A double-blind, placebo-controlled study to determine the efficacy of Nicobrevin anti-smoking capsules.
Dankwa
E
E
Perry
L
L
Perkins
A
A
D000328:Adult; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D008297:Male; D010421:Pentanoic Acids / Q000008:administration & dosage / Q000627:therapeutic use*; D011446:Prospective Studies; D011803:Quinine / Q000008:administration & dosage / Q000627:therapeutic use*; D000074606:Smoking Prevention; D013729:Terpenes / Q000008:administration & dosage / Q000627:therapeutic use*; D014631:Valerates / Q000627:therapeutic use*
D010421:Pentanoic Acids; D013729:Terpenes; D014631:Valerates; C060496:nicobrevin; D011803:Quinine